144 related articles for article (PubMed ID: 14586159)
1. Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder.
Maayan R; Yoran-Hegesh R; Strous R; Nechmad A; Averbuch E; Weizman A; Spivak B
Neuropsychobiology; 2003; 48(3):111-5. PubMed ID: 14586159
[TBL] [Abstract][Full Text] [Related]
2. Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.
Lee MS; Yang JW; Ko YH; Han C; Kim SH; Lee MS; Joe SH; Jung IK
Child Psychiatry Hum Dev; 2008 Jun; 39(2):201-9. PubMed ID: 17763937
[TBL] [Abstract][Full Text] [Related]
3. Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate.
Wang LJ; Hsiao CC; Huang YS; Chiang YL; Ree SC; Chen YC; Wu YW; Wu CC; Shang ZY; Chen CK
Psychoneuroendocrinology; 2011 Sep; 36(8):1209-16. PubMed ID: 21411231
[TBL] [Abstract][Full Text] [Related]
4. Salivary neurosteroid levels and behavioural profiles of children with attention-deficit/hyperactivity disorder during six months of methylphenidate treatment.
Wang LJ; Wu CC; Lee SY; Tsai YF
J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):336-40. PubMed ID: 24956271
[TBL] [Abstract][Full Text] [Related]
5. Analysis of neurosteroid levels in attention deficit hyperactivity disorder.
Strous RD; Spivak B; Yoran-Hegesh R; Maayan R; Averbuch E; Kotler M; Mester R; Weizman A
Int J Neuropsychopharmacol; 2001 Sep; 4(3):259-64. PubMed ID: 11602031
[TBL] [Abstract][Full Text] [Related]
6. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
Wang LJ; Chen CK; Huang YS
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
[TBL] [Abstract][Full Text] [Related]
8. Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology.
Molina-Carballo A; Justicia-Martínez F; Moreno-Madrid F; Cubero-Millán I; Machado-Casas I; Moreno-García L; León J; Luna-Del-Castillo JD; Uberos J; Muñoz-Hoyos A
Psychopharmacology (Berl); 2014 Sep; 231(17):3635-45. PubMed ID: 24599397
[TBL] [Abstract][Full Text] [Related]
9. Changes in plasma Brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with Attention deficit-hyperactivity disorder (ADHD).
Amiri A; Torabi Parizi G; Kousha M; Saadat F; Modabbernia MJ; Najafi K; Atrkar Roushan Z
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():20-4. PubMed ID: 23933054
[TBL] [Abstract][Full Text] [Related]
10. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
[TBL] [Abstract][Full Text] [Related]
11. Gender Differences in the Behavioral Symptoms and Neuropsychological Performance of Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate: A Two-Year Follow-up Study.
Wang LJ; Chen CK; Huang YS
J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):501-8. PubMed ID: 26262904
[TBL] [Abstract][Full Text] [Related]
12. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
13. Effects of stimulants and atomoxetine on cortisol levels in children with ADHD.
Isaksson J; Hogmark Å; Nilsson KW; Lindblad F
Psychiatry Res; 2013 Oct; 209(3):740-1. PubMed ID: 23850434
[TBL] [Abstract][Full Text] [Related]
14. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
[TBL] [Abstract][Full Text] [Related]
15. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
[TBL] [Abstract][Full Text] [Related]
16. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
17. Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
Tan M; Appleton R
Arch Dis Child; 2005 Jan; 90(1):57-9. PubMed ID: 15613514
[TBL] [Abstract][Full Text] [Related]
18. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
[TBL] [Abstract][Full Text] [Related]
19. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
Ince Tasdelen B; Karakaya E; Oztop DB
J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
[TBL] [Abstract][Full Text] [Related]
20. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
